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Abstract
We report a case of phenytoin-induced pseudolymphoma in a 28
of  autism  and  seizure  disorder.  The  patient  presented  with  bilateral  cervical 
lymphadenopathy that was shown
PET/CT scan.  Flow cytometry analysis of peripheral blood and bone marrow mononuclear 
cells detected identical T cell population with aberrant immunophenotype.  Additionally, a 
TCR  beta  gene  was  found  to  be  clonally  rearranged  in  both  peripheral  blood  and  bone 
marrow supporting a clonal origin of atypical T cells. However, no such clonal population of 
T-cells could be detected in a pathologic specimen obtained from an excisional biopsy of one 
of  the  patient’s  cervical  lymph  nodes.  After  discontinuing  the  patient’s  phenytoin,  his 
lymphadenopathy  has  nearly  completely  resolved  and  circulation  clonal  T  cell  population 
disappeared with 12 months of follow
Case  Report:  In  June,  2007  a  28-year
with a history of autism and seizure disorder treated 
with phenytoin, was referred to our institution with 
a  diagnosis  of  angioimmunoblastic  T
lymphoma. The patient had originally presented to 
his  primary  care  physician  with  a  complaint  of 
bilateral  cervical  lymphadenopathy  and  4  kg 
unintentional weight loss in November 2006.   After 
several weeks of observation, an excisional biopsy 
of  a  right-sided  cervical  lymph  node  was 
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induced pseudolymphoma in a 28-year-old male with a history 
of  autism  and  seizure  disorder.  The  patient  presented  with  bilateral  cervical 
lymphadenopathy that was shown to be moderately to markedly FDG-avid on a whole body 
PET/CT scan.  Flow cytometry analysis of peripheral blood and bone marrow mononuclear 
cells detected identical T cell population with aberrant immunophenotype.  Additionally, a 
to  be  clonally  rearranged  in  both  peripheral  blood  and  bone 
marrow supporting a clonal origin of atypical T cells. However, no such clonal population of 
cells could be detected in a pathologic specimen obtained from an excisional biopsy of one 
ient’s  cervical  lymph  nodes.  After  discontinuing  the  patient’s  phenytoin,  his 
lymphadenopathy  has  nearly  completely  resolved  and  circulation  clonal T  cell  population 
disappeared with 12 months of follow-up.
year-old  male 
with a history of autism and seizure disorder treated 
with phenytoin, was referred to our institution with 
a  diagnosis  of  angioimmunoblastic  T-cell 
lymphoma. The patient had originally presented to 
n  with  a  complaint  of 
bilateral  cervical  lymphadenopathy  and  4  kg 
unintentional weight loss in November 2006.   After 
several weeks of observation, an excisional biopsy 
sided  cervical  lymph  node  was 
performed.  Histology  revealed  an  atypical  and 
partially effaced architecture consisting of a nodular 
proliferation and a marked interfollicular expansion 
(Figures  1).  Flow  cytometry  and 
histochemistry did not demonstrate evidence of a B
cell  lymphoma.  Molecular  analysis  of  the  TCR 
gamma gene failed to reveal a clonal population and 
molecular analysis of the TCR beta gene was not 
performed at that time. Nonetheless, based on the 
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old male with a history 
of  autism  and  seizure  disorder.  The  patient  presented  with  bilateral  cervical 
avid on a whole body 
PET/CT scan.  Flow cytometry analysis of peripheral blood and bone marrow mononuclear 
cells detected identical T cell population with aberrant immunophenotype.  Additionally, a 
to  be  clonally  rearranged  in  both  peripheral  blood  and  bone 
marrow supporting a clonal origin of atypical T cells. However, no such clonal population of 
cells could be detected in a pathologic specimen obtained from an excisional biopsy of one 
ient’s  cervical  lymph  nodes.  After  discontinuing  the  patient’s  phenytoin,  his 
lymphadenopathy  has  nearly  completely  resolved  and  circulation  clonal  T  cell  population 
performed.  Histology  revealed  an  atypical  and 
partially effaced architecture consisting of a nodular 
proliferation and a marked interfollicular expansion 
).  Flow  cytometry  and  immune-
histochemistry did not demonstrate evidence of a B-
cell  lymphoma.  Molecular  analysis  of  the  TCR 
iled to reveal a clonal population and 
molecular analysis of the TCR beta gene was not 
performed at that time. Nonetheless, based on the Medit J Hemat Infect Dis 2010; 2(3); Open Journal System 
histological  and  immunophenotypic  features,  a 
diagnosis of angioimmunoblastic T-cell lymphoma 
was rendered and the patient was recommended to 
undergo treatment with combine chemotherapy.
At  the  time  of  initial  consultation  at  our 
institution, the patient’s physical examination was 
significant  for  palpable  bilateral  cervical 
lymphadenopathy.  The  largest  lymph  node  was  a 
right-sided level V lymph node that measured 2.9 x 
2.0  cm  on  CT.    His  abdomen  showed  no 
hepatosplenomegaly and his skin was negative for 
dermatitis. His CBC showed a WBC of 6,400/µL, a 
platelet  count  of  324,000/µL,  and  hemoglobin  of 
11.8 g/dL.  Chemistry panel was unremarkable with 
normal LDH of 429 U/L. 
The  whole  body  PET/CT  revealed  multiple 
moderately  enlarged  lymph  nodes  throughout  the 
upper, mid, and lower cervical stations bilaterally, 
and also involving the right tonsillar region.  These 
nodes  exhibited  moderate  to  marked 
hypermetabolic  activity  (Figure  2).  No  other 
hypermetabolic foci were noted.
Flow  cytometry  of  the  peripheral  blood 
revealed a small T-cell population accounting for 
Figure 1.
A. Follicular  atrophy  and  atypical  interfollicular  hyperplasia. 
Partially  effaced  architecture  of  lymph  node  with  a  nodular 
proliferation  composed  of  atrophic  germinal  centers  with 
prominent  vasculature  accompanied  by  marked interfollicular 
expansion.  Hypoplastic  and  sclerotic  germinal  centers  are 
surrounded  and  infiltrated  by  small  lymphocytes.  (10x) 
(hematoxylin-eosin)
B. Atypical  interfollicular  hyperplasia.  Numerous 
immunoblasts and plasmacytoid lymphocytes are accompanied 
by  small  mature  lymphocytes  and  histiocytes.  (60x  oil 
immersion) (hematoxylin-eosin).  
C. Immunohistochemistry for CD20. Nodular regions of lymph 
node consist predominantly of small T-lymphocytes (negative 
staining) surrounded by a compressed mantle zone and partially 
intact  marginal  zone  containing  CD20+  B-lymphocytes. 
Hypoplastic  germinal  centers  contain  few  residual  CD20+ 
lymphocytes.  Interfollicular  immunoblasts  consist 
predominantly of T-cells. (10x)(CD20 immunoperoxidase) 
approximately  1.5%  of  the  total  analyzed  cells.  
These cells lacked expression of CD7 and weakly 
expressed  CD5.  Gene  rearrangement  studies 
revealed a clonal population with rearrangement of 
the  TCR  beta  gene.  The  TCR  gamma  gene 
rearrangement  study  was  negative.  The  bone 
marrow  biopsy  and  aspirate  revealed  a 
normocellular  marrow  with  adequate  trilineage 
maturing  hematopoiesis  and  14%  atypical 
lymphocytes  on  a  200  cell  differential.  
Cytogenetics revealed a normal male karyotype, 46, 
XY. TCR beta gene rearrangement study revealed a 
clonal population with an identical fragment length 
to that identified in the peripheral blood. Review of 
the  original  pathologic  material  confirmed  the 
atypical  and  partially  effaced  architecture.   
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Figure 2.  Whole body FDG- PET/CT Scan. Increased FDG-
PET uptake in enlarged bilateral cervical lymphonodes.
done on paraffin  embedded tissue of  lymphonode 
revealed  germinal  configuration.  Based  on  the 
patient’s  history  of  recurrent  lymphadenopathy, 
phenytoin exposure, and inability to demonstrate a 
clonal  population  of  T  cells  in  the  affected
lymphonode,  a  diagnosis  of  phenytoin-induced 
pseudolymphoma was rendered and his phenytoin 
was discontinued. At follow up in June, 2008 his 
cervical  lymph  nodes  had  diminished in  size and 
were  approximately  0.5  cm  in  diameter.    Repeat 
flow cytometry of peripheral blood and TCR gene 
rearrangement studies showed no evidence of clonal 
T-cell population.  
Discussion: Lymphadenopathy in association with 
the use of hydantoin derivatives such as phenytoin 
was first described  in  1940. Over  the years there 
have  been  multiple  case  reports  and  small  series 
published describing this occurrence and variously 
terming  it  Dilantin-associated  lymphadenopathy, 
phenytoin-induced  pseudolymphoma,  and  anti-
convulsant hypersensitivity syndrome.  More recent 
publications generally divide these occurrences into 
two  groups:  the  anticonvulsant  hypersensitivity 
syndrome  and  phenytoin-induced  pseudo-
lymphoma.  The  anticonvulsant  hypersensitivity 
syndrome is a rare syndrome characterized by fever, 
rash, lymphadenopathy, eosinophilia, and hepatitis.  
It generally develops within eight weeks after the 
drug is first prescribed. The presenting symptoms 
are fever and malaise in most patients. Later, a rash 
generally starts as a macular erythema involving the 
upper trunk and face and evolves into a symmetric, 
pruritic,  confluent,  papular  rash  that  eventually 
involves  the  lower  extremities.  The  lymphoid 
reaction  pattern  most  commonly  seen  in  this 
syndrome  is  a  benign  lymphoid  follicular 
hyperplasia.  Patients  generally  do  well  with 
discontinuation  of  the  anticonvulsant,  though 
corticosteroids  have  been  used  in  more  severe 
cases.Errore.  Il  segnalibro  non  è  definito. In 
contradistinction  to  the  anticonvulsant 
hypersensitivity  syndrome,  phenytoin-induced 
pseudolymphoma is considered to be a late effect of 
phenytoin  therapy,  which  can  occur  years  after 
initiating  treatment.Errore.  Il  segnalibro  non  è 
definito.
,Errore. Il segnalibro non è definito.  This term 
applies  to  those  patients  with  histological  and 
clinical  features  suggestive  of  lymphoma.    These 
patients  have  an  atypical lymph  node hyperplasia 
that  distorts  or  effaces  the  normal  lymph  node 
architecture with an atrophic germinal center.Errore. 
Il  segnalibro  non  è  definito. Fever,  hepatitis,  and 
eosinophilia are generally absent.Errore. Il segnalibro 
non  è  definito.
,Errore.  Il  segnalibro  non  è  definito.  
When a rash is present and a biopsy is obtained, the 
histological  appearance  may  mimic  that  of  a 
cutaneous T-cell lymphoma.Errore. Il segnalibro non è 
definito. Treatment  consists  of  discontinuing 
Dilantin.  Glucocortcoids  have  been  used  with 
success when symptoms persist despite withdrawal 
of  Dilantin.  In  this  case,  a  PET  scan  revealed 
multiple  moderately  enlarged  lymph nodes  in  the 
neck  that  exhibited  moderate  to  marked 
hypermetabolism.  While  to  our  knowledge  such 
hypermetabolism  of  [18F]-fluoro-2-deoxyglucose 
(FDG)  has  not  been  previously  described,  this  is 
consistent  with  another  case  report  which 
demonstrated increased uptake on a gallium scan. 
Also particular to this case was the detection of a 
small  monoclonal  population  of  T-cells  in  the 
peripheral blood and marrow aspirate, but not in the 
excised  lymph  node.  The  absence  of  a  clonal 
population of T-cells in the lymph node aided in the Medit J Hemat Infect Dis 2010; 2(3); Open Journal System 
diagnosis  of  phenytoin-induced  pseudolymphoma, 
and it has been suggested that this is the method of 
choice to distinguish between pseudolymphoma and 
a T-cell lymphoma.Errore. Il segnalibro non è definito.
The detection of a clonal population of T-cells in 
the peripheral blood of otherwise healthy adults has 
been  reported  before  and  should  not  be  the  sole 
criteria  upon  which  the  diagnosis  of  a  T-cell 
malignancy rests. The mechanisms underlying the 
development  of  lymphadenopathy  in  patients 
treated  with  phenytoin  are  not  completely 
understood.    With  regards  to  the  anticonvulsant 
hypersensitivity  syndrome,  it  has  been  proposed 
that abnormal detoxification of reactive metabolites 
of  phenytoin,  possibly  arene  oxide  metabolites 
produced  by  cytochrome  P450,  is  responsible  for 
the  syndrome.Errore.  Il  segnalibro  non  è  definito.
Whether the pathophysiology of phenytoin-induced 
pseudo-lymphoma is similar remains unknown.
In  summary,  this  case  report  describes  the 
presentation of the rare but important syndrome of 
phenytoin-induced  pseudolymphoma  and  adds  to 
the  available  body  of  literature  describing  this 
entity.  This  case  is  unique  in  that  the  involved 
lymph nodes were shown to be FDG-avid and that a 
small clonal population of T-cells was demonstrated 
in the patient’s peripheral blood and bone marrow, 
but  not  in  the  excised  lymph  node.  Such  a  case 
could be easily mistaken for a T-cell lymphoma and 
should serve as a reminder that careful review of a 
patient’s clinical and pathologic data are mandatory 
before initiating cytotoxic chemotherapy.
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